Downregulation of ATM was also suggested in 3 mouse models for AD, transgenic mice expressing mutants of APP, PSEN1/APP, or PSEN1/APP/MAPT (encoding tau) [88]. This evidence concerns the gene MAPT and Alzheimer disease.